A significant breakthrough in cancer investigation is occurring with the use of mini-antibodies to re-engage mutated p53. This essential malignant suppressor protein is frequently inactivated in many types of cancer, https://kingbookmark.com/story22008445/nanobodies-revive-tumor-suppressor-p53-the-new-pathway-for-malignant-treatment